Miyoshi, J., Maeda, T., Matsuoka, K., Saito, D., Miyoshi, S., Matsuura, M., . . . Hisamatsu, T. (2021). Machine learning using clinical data at baseline predicts the efficacy of vedolizumab at week 22 in patients with ulcerative colitis. Nature Portfolio.
Cita Chicago Style (17a ed.)Miyoshi, Jun, Tsubasa Maeda, Katsuyoshi Matsuoka, Daisuke Saito, Sawako Miyoshi, Minoru Matsuura, Susumu Okamoto, Satoshi Tamura, y Tadakazu Hisamatsu. Machine Learning Using Clinical Data at Baseline Predicts the Efficacy of Vedolizumab at Week 22 in Patients with Ulcerative Colitis. Nature Portfolio, 2021.
Cita MLA (8a ed.)Miyoshi, Jun, et al. Machine Learning Using Clinical Data at Baseline Predicts the Efficacy of Vedolizumab at Week 22 in Patients with Ulcerative Colitis. Nature Portfolio, 2021.